In order to achieve its investment objective
The Biotech Growth Trust invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Share price
View share price detail
Factsheets
-
2024 AGM Investor Presentation
-
Investor Update Presentation - March 2024
-
Investor Update Presentation
How to invest
The Company’s shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.
£351.8m
Our Net Asset Value*
29.3%
Five year share price (total return)*
27.1%
Five year Net Asset Value per share (total return)*
Source: Frostrow Capital LLP
*As at 30 June 2024
Register for email alerts
Read the latest Regulatory News Service (RNS) announcements from The Biotech Growth Trust.
Sign up to The Biotech Growth Trust mailing list for our monthly factsheet.
Investor Disclosure Document